FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against coronavirus (COVID-19), in Cambridge, Massachusetts, USA, May 18, 2020. REUTERS / Brian Snyder (Reuters) – Drug Developer Moderna Inc (MRNA.O) on Friday said it has so far enrolled 13,194 participants in the ongoing 30,000-volunteer …
Read More »
(Reuters) – The following is a roundup of some of the latest scientific studies on the new coronavirus and efforts to find treatments and vaccines for COVID-19, the disease caused by the virus. New questions about inhibitor COVID-19 efficacy A new study raises fresh questions about the effectiveness of Gilead …
Read More »
(Reuters) – The U.S. Food and Drug Administration was able to update its emergency use authorization for Gilead Sciences Inc’s (GILD.O) brakesivir of drugs to admit patients admitted to hospital with moderate COVID-19, despite mixed test results, the company’s top study said on Friday. FILE PHOTO: An ampoule of Ebola …
Read More »
CHICAGO (Reuters) – U.S. government scientists have begun efforts to create a strain of the new coronavirus that could be used in human challenge tests of vaccines, a controversial type of study in which healthy volunteers would vaccinate and then deliberately infect with the virus, Reuters has learned. FILE PHOTO: …
Read More »
MOSCOW (Reuters) – Russia’s first potential COVID-19 vaccine will obtain local regulatory approval in the first half of August and be administered to front-line health workers soon after, a development source close to the matter told Reuters. FILE PHOTO: The Executive President of the Russian Direct Investment Fund, Kirill Dmitriev, …
Read More »